Princeton Global Asset Management LLC Denali Therapeutics Inc. Transaction History
Princeton Global Asset Management LLC
- $507 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding DNLI
# of Institutions
245Shares Held
120MCall Options Held
91.1KPut Options Held
78.4K-
Black Rock Inc. New York, NY13.2MShares$282 Million0.01% of portfolio
-
Baillie Gifford & CO12.3MShares$263 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$257 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA9.85MShares$210 Million0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.48MShares$117 Million0.02% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $2.87B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...